Does berberine cause hair loss? This is a question increasingly asked by UK supplement users as berberine grows in popularity for its potential metabolic benefits. Berberine is a plant-derived alkaloid sold widely as a food supplement in the UK, used to support blood glucose regulation, lipid metabolism, and weight management. Whilst current clinical evidence does not confirm a direct link between berberine and hair loss, certain indirect biological mechanisms — including possible effects on thyroid function and nutrient absorption — have been proposed. This article examines what the evidence shows, explores other potential causes of hair loss, and advises when to seek professional medical guidance.

What Is Berberine and How Is It Used in the UK?

Berberine is a plant-derived alkaloid sold in the UK as an unregulated food supplement, not a licensed medicine, commonly used to support blood glucose and lipid metabolism. It can interact with several prescribed medicines and is not a substitute for medical treatment.

Worried about interactions with other medications? Speak to one of our pharmacists →

Berberine is a naturally occurring alkaloid found in several plants, including barberry (Berberis vulgaris), goldenseal, and tree turmeric. It has been used for centuries in traditional Chinese and Ayurvedic medicine, primarily for its antimicrobial and anti-inflammatory properties. In recent years, berberine has attracted considerable attention in the UK as a dietary supplement, largely due to emerging research into its potential effects on blood glucose regulation, lipid metabolism, and weight management.

In the UK, berberine is sold as a food supplement, not a licensed medicine. As such, it falls under food law, overseen by the Food Standards Agency (FSA) and enforced by Trading Standards, rather than being regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) in the way that prescription or over-the-counter medicines are. This means that pre-market evidence of safety and efficacy is not required to the same standard as for licensed medicines, and product quality, dosage, and purity can vary significantly between brands.

There is no established UK-recommended dose for berberine. Doses used in research studies and reflected on product labels typically range from 500 mg to 1,500 mg per day, often taken in divided doses with meals — but these figures should not be read as dosing guidance.

Berberine is thought to exert metabolic effects partly through activation of AMP-activated protein kinase (AMPK), an enzyme involved in cellular energy regulation. This mechanism has been compared to that of metformin in preclinical and early clinical research; however, the evidence base is not equivalent, and berberine is not a licensed treatment for type 2 diabetes or any other medical condition in the UK. It must not be used as a substitute for prescribed therapies without medical supervision.

Berberine also has a number of important safety considerations that are not always highlighted on supplement packaging. Common adverse effects reported in clinical studies include gastrointestinal symptoms such as diarrhoea, constipation, abdominal discomfort, and nausea. Berberine inhibits certain drug-metabolising enzymes and transporters — including CYP3A4 and P-glycoprotein — which means it can interact with a range of medicines, including antidiabetic drugs (increasing the risk of hypoglycaemia), antihypertensives, anticoagulants, and drugs with a narrow therapeutic index such as calcineurin inhibitors (e.g., ciclosporin). Berberine is not recommended during pregnancy or breastfeeding. People with hepatic or renal impairment should seek medical advice before use. Anyone taking prescribed medicines should consult their GP or pharmacist before starting berberine.

Experiencing these side effects? Our pharmacists can help you navigate them →

What the Evidence Says About Berberine and Hair Changes

Current evidence does not confirm that berberine directly causes hair loss; however, limited data suggest it may modestly affect thyroid hormone levels, an indirect pathway that warrants monitoring in susceptible individuals.

One of the questions increasingly raised by supplement users is: does berberine cause hair loss? At present, there is no robust clinical evidence from large-scale, controlled human trials that directly links berberine supplementation to hair loss or alopecia. Hair loss does not appear as a recognised or commonly reported adverse effect in available systematic reviews or clinical studies of berberine.

However, two indirect biological mechanisms are sometimes discussed, and it is important to consider these with appropriate caution.

Firstly, some studies have suggested that berberine may influence thyroid function. A small number of human studies — predominantly in people with specific metabolic conditions — have reported modest reductions in thyroid hormone levels (T3 and T4) and increases in thyroid-stimulating hormone (TSH) with berberine use. However, this evidence is limited, inconsistent, and not yet sufficient to draw firm conclusions. Since hypothyroidism is a well-established cause of diffuse hair thinning, individuals with pre-existing thyroid conditions or borderline thyroid function should be aware of this potential interaction and discuss it with their GP. Those using berberine long term may wish to have thyroid function monitored.

Secondly, it has been proposed that berberine may affect the absorption of certain nutrients — including folate and vitamin B12 — through changes to gut microbiota and intestinal function. Deficiencies in these nutrients are associated with hair thinning. However, this remains a theoretical concern based on limited preclinical data; there is currently insufficient human clinical evidence to confirm this effect, and it should not be presented as established fact.

In summary, current evidence does not confirm that berberine directly causes hair loss. The indirect pathways described above — particularly potential thyroid effects — are plausible but unproven in humans and require further investigation. Anyone concerned about hair changes whilst taking berberine should seek advice from a GP or pharmacist.

Other Factors That May Contribute to Hair Loss

Hair loss is multifactorial, with common causes including androgenetic alopecia, telogen effluvium, thyroid disorders, nutritional deficiencies, and medications — all of which must be considered before attributing shedding to berberine.

When evaluating whether berberine is responsible for hair loss, it is essential to consider the broader clinical picture. Hair loss is a multifactorial condition with numerous potential causes, and attributing it to a single supplement without thorough investigation can lead to missed diagnoses.

Common causes of hair loss in the UK include:

• Androgenetic alopecia — the most prevalent form, affecting both men and women, driven by genetic and hormonal factors

• Telogen effluvium — diffuse shedding often triggered by physical or emotional stress, illness, surgery, or significant weight loss

• Thyroid disorders — both hypothyroidism and hyperthyroidism can cause hair thinning

• Nutritional deficiencies — particularly iron deficiency anaemia, low ferritin, and inadequate protein intake

• Hormonal changes — including postpartum hair loss, polycystic ovary syndrome (PCOS), and the menopause

• Autoimmune conditions — such as alopecia areata

• Scalp infections — tinea capitis (scalp ringworm) is an important and treatable cause, particularly in children, and requires prompt diagnosis to prevent spread and hair loss

• Scarring alopecias — conditions such as lichen planopilaris and folliculitis decalvans can cause permanent hair loss if not identified and treated promptly; early specialist assessment is important

• Medications — a wide range of prescribed medicines are known to cause hair loss as a side effect, including anticoagulants, antidepressants, antiepileptics, antithyroid drugs, retinoids, hormonal therapies, and chemotherapy agents; any recently started or changed prescription should be reviewed

It is also worth noting that many individuals who take berberine do so because they have metabolic conditions such as insulin resistance, PCOS, or obesity — all of which are independently associated with hair loss. This makes it particularly challenging to isolate berberine as a causative factor without controlled investigation.

If you have recently started taking berberine and noticed increased hair shedding, consider whether any other lifestyle, dietary, or health changes have occurred concurrently, and discuss these with a healthcare professional before discontinuing the supplement. Further information on common causes of hair loss is available on the NHS website.

When to Speak to a GP or Pharmacist About Hair Loss

Seek GP advice if hair loss is sudden, patchy, accompanied by systemic symptoms, or associated with scalp changes, as some causes such as scarring alopecia and tinea capitis require prompt treatment to prevent permanent loss.

Hair loss can be distressing, and whilst it is often benign and self-limiting, there are circumstances in which it warrants prompt medical assessment. If you are taking berberine and experiencing noticeable hair thinning or shedding, it is advisable to seek professional advice rather than self-diagnosing or abruptly stopping the supplement.

You should consider speaking to your GP if you notice:

• Sudden or rapid hair loss over a short period

• Patchy hair loss or bald spots, which may suggest alopecia areata

• Hair loss accompanied by other symptoms, such as fatigue, weight changes, cold intolerance, or irregular periods — which could indicate a thyroid or hormonal disorder

• Scalp changes, including redness, scaling, inflammation, or scarring — scarring alopecia and tinea capitis in particular require prompt assessment, as delayed treatment can result in permanent hair loss

• Hair loss in a child, which should always be assessed by a GP

• Hair loss that is affecting your mental wellbeing or daily functioning

Your GP will take a focused history and examination to guide any investigations. In UK primary care, blood tests are targeted to the clinical picture rather than ordered routinely. Tests that may be considered include a full blood count (FBC), serum ferritin, and thyroid function tests (TFTs). Androgen levels are generally checked only when there are clinical features suggesting hyperandrogenism (for example, in women with PCOS, irregular periods, or hirsutism), in line with NICE guidance. Additional tests may be arranged based on individual findings.

If scarring alopecia or tinea capitis is suspected, expedited referral to a dermatologist or, for tinea capitis in children, appropriate specialist assessment, is recommended. NICE Clinical Knowledge Summaries (CKS) and the Primary Care Dermatology Society (PCDS) provide guidance for clinicians on the assessment and investigation of hair loss in primary care.

A pharmacist can also be a valuable first point of contact. They can review your current supplements and medications for potential interactions or side effects, and help determine whether a GP referral is warranted. If you are taking berberine alongside prescribed medicines — particularly antidiabetic drugs, antihypertensives, anticoagulants, or thyroid treatments — it is especially important to seek pharmacist or GP advice, as berberine may interact with these treatments and alter their efficacy or safety.

Reporting Side Effects: MHRA Yellow Card Scheme

Suspected adverse reactions to berberine, including hair loss, should be reported to the MHRA via the Yellow Card scheme, which monitors safety signals for unlicensed supplements as well as licensed medicines.

In the UK, the MHRA operates the Yellow Card scheme, which is the national system for collecting and monitoring reports of suspected side effects or adverse reactions to medicines, vaccines, and — importantly — herbal and complementary products, including food supplements such as berberine.

Although berberine is not a licensed medicine, the Yellow Card scheme encourages reports of suspected adverse reactions to unlicensed herbal products and supplements. This is particularly valuable because supplements are not subject to the same pre-market safety and efficacy testing as licensed medicines, meaning post-market surveillance through schemes like Yellow Card plays a critical role in identifying emerging safety signals.

If you suspect that berberine has caused or contributed to hair loss or any other unexpected symptom, you can submit a report directly via the MHRA Yellow Card website (yellowcard.mhra.gov.uk) or through the Yellow Card app. Reports can be submitted by both patients and healthcare professionals. The information you provide contributes to the national evidence base and may help protect other supplement users in the future.

When submitting a report, it is helpful to include:

• The brand name and dose of the berberine supplement

• How long you have been taking it

• A description of the symptom(s) experienced and when they began

• Any other medicines or supplements you are taking

• Relevant medical history

Reporting suspected side effects — even when a definitive link is uncertain — is an important act of public health responsibility. It supports the MHRA's ongoing work to ensure that products available to UK consumers are as safe as possible, and helps build a clearer picture of the real-world effects of widely used supplements like berberine.

Frequently Asked Questions